Ameriprise Financial Inc Charles River Laboratories International, Inc. Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 282,736 shares of CRL stock, worth $58.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

282,736

Previous 23,585 1098.8%

Holding current value

$58.9 Million

Previous $5.58 Million 1274.12%

% of portfolio

0.02%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $52.7 Million - $70.9 Million	259,151 Added 1098.8%	282,736 $76.6 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $233,124 - $338,436	-1,417 Reduced 5.67%	23,585 $5.58 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $289,715 - $324,238	1,490 Added 6.34%	25,002 $4.9 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $237,169 - $271,432	1,291 Added 5.81%	23,512 $4.94 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $56.9 Million - $77 Million	-296,276 Reduced 93.02%	22,221 $4.48 Million

Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $59.1 Million - $75 Million	299,953 Added 1617.52%	318,497 $69.4 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $201,231 - $276,345	-1,103 Reduced 5.61%	18,544 $3.65 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $1.43 Million - $2.12 Million	-7,019 Reduced 26.32%	19,647 $4.2 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $204,919 - $290,412	-802 Reduced 2.92%	26,666 $7.45 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $81.5 Million - $104 Million	-231,940 Reduced 89.41%	27,468 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $217 Million - $267 Million	-581,623 Reduced 69.16%	259,408 $107 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $19.8 Million - $25.1 Million	-67,474 Reduced 7.43%	841,031 $311 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $60.3 Million - $72.3 Million	-241,402 Reduced 20.99%	908,505 $263 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $86.2 Million - $98.1 Million	388,345 Added 50.99%	1,149,907 $287 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $78.7 Million - $101 Million	448,012 Added 142.88%	761,562 $172 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $284,027 - $453,430	2,390 Added 0.77%	313,550 $54.6 Million
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $13.5 Million - $24.3 Million	-136,109 Reduced 30.43%	311,160 $39.2 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $29.2 Million - $35.4 Million	-231,850 Reduced 34.14%	447,269 $68.3 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $13.9 Million - $16 Million	111,365 Added 19.62%	679,119 $89.9 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $17.6 Million - $21.2 Million	142,415 Added 33.48%	567,754 $80.6 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $7.37 Million - $10.3 Million	70,276 Added 19.79%	425,339 $61.8 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $2.23 Million - $2.91 Million	-21,240 Reduced 5.64%	355,063 $40.2 Million
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $13.3 Million - $15.9 Million	118,496 Added 45.96%	376,303 $50.5 Million
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $7.11 Million - $8.14 Million	69,463 Added 36.88%	257,807 $28.9 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $761,365 - $893,260	7,754 Added 4.29%	188,344 $20.1 Million
Q4 2017 Feb 12, 2018	SELL	$100.43 - $118.09 $527,960 - $620,799	-5,257 Reduced 2.83%	180,590 $19.8 Million
Q3 2017 Nov 07, 2017	BUY	$96.72 - $109.26 $18 Million - $20.3 Million	185,847	185,847 $20.1 Million

Others Institutions Holding CRL

# of Institutions

726

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.6B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Charles River Laboratories International, Inc. Transaction History